#Japan #Adachi #ED Treatment #Vigor 2020 #Japanese guidelines

Vigor 2020: A Breakthrough in Erectile Dysfunction Treatment

On September 19, 2025, the "Guidelines for the Treatment of Male Sexual Dysfunction" edited by the Japanese Society of Sexual Medicine and the Japanese Urological Association officially included "Vigor 2020", a medical device offered by A&H B Co., Ltd., located in Adachi, Tokyo. This landmark recognition signifies a substantial step forward in the treatment landscape for erectile dysfunction (ED) in Japan.

Current Status of Vacuum Erection Devices in Japan

In Japan, vacuum erection devices (VEDs) have evolved significantly since the Japanese Society of Sexual Medicine petitioned the Ministry of Health, Labour and Welfare to classify them as medical devices. As of October 1, 1998, these devices were classified as medical equipment requiring manufacturing, import, and sales approval from the Health Ministry. The revision of the Pharmaceutical Affairs Law in April 2005 further categorized VEDs as Class II medical devices, meaning that they require sales approval from the Ministry of Health, Labour and Welfare before they can be marketed.

Vigor 2020's Recognition in the New Guidelines

The inclusion of Vigor 2020 in the new treatment guidelines is a significant milestone for both physicians and patients. By explicitly naming this vacuum erection device, the guidelines provide healthcare professionals with a trusted option to recommend to patients who may not respond to PDE5 inhibitors. Vigor 2020, which began sales in Japan following its approval by PMDA in 2021, is the only vacuum erection device currently available in Japan.

This explicit mention in the guidelines ensures that doctors can confidently incorporate Vigor 2020 into their treatment plans, thus broadening the scope of available therapeutic options for patients suffering from erectile dysfunction.

Rehabilitation Post-Prostate Cancer Treatment

An important aspect of the newly released guidelines is their mention of the use of vacuum erection devices in penile rehabilitation post-prostate cancer treatment. The guidelines indicate that employing such devices can help prevent fibrosis and atrophy of the penis, a vital point for patient recovery. Vigor 2020 is currently the only vacuum erection device in Japan endorsed for use in rehabilitation therapies. This endorsement supports the implementation of evidence-based practices in the rehabilitation of patients undergoing treatment for prostate cancer.

A&H B's Commitment to Healthcare

The recognition of Vigor 2020 in a specialized clinical guideline highlights the anticipated role this device will play in helping medical professionals provide well-informed choices to their patients. A&H B's mission is to promote health and happiness across society through the provision of innovative medical devices.

Our commitment spans across various aspects, including fostering healthy work environments, enhancing quality of life through wellness initiatives, and supporting preconception care for future generations.

As we move forward, A&H B remains devoted to delivering honest and passionate options that contribute meaningfully to healthcare practices.

Company Overview

• - Company Name: A&H B Co., Ltd.
• - Location: 5-17-9 Ayase, Adachi, Tokyo
• - CEO: Kenji Furuyama
• - Website: A&H B

Contact Information

• - Customer Center for Vigor 2020
• - Phone: 03-6820-2089 (Monday to Friday, 10 AM - 5 PM, excluding weekends and holidays)
• - Email: [email protected]
• - Contact Form: Contact Us

This recognition by a specialized medical association not only emphasizes Vigor 2020's credibility but also reinforces our ongoing commitment to enhance patient care and treatment outcomes in the field of men's health.